FDA Approved: OXCARBAZEPINE — Supplemental Application (EPIC PHARMA, LLC)

View source ↗

Summary

FDA approved a supplemental application for oxcarbazepine submitted by Epic Pharma, LLC, authorizing a generic formulation under ANDA 215332.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)